HealthCor Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-51,240
| Closed | -$26M | – | 54 |
|
|
2022
Q3 | $26M | Buy |
+51,240
| New | +$26M | 3.25% | 10 |
|
|
2021
Q3 | – | Sell |
-182,970
| Closed | -$92.3M | – | 85 |
|
|
2021
Q2 | $92.3M | Buy |
+182,970
| New | +$92.3M | 3.69% | 10 |
|
|
2020
Q3 | – | Sell |
-152,180
| Closed | -$55.1M | – | 55 |
|
|
2020
Q2 | $55.1M | Buy |
152,180
+92,180
| +154% | +$33.4M | 2.31% | 22 |
|
|
2020
Q1 | $17M | Buy |
+60,000
| New | +$17M | 0.73% | 34 |
|
|
2019
Q2 | – | Sell |
-157,520
| Closed | -$43.1M | – | 63 |
|
|
2019
Q1 | $43.1M | Buy |
+157,520
| New | +$43.1M | 1.74% | 22 |
|
|
2018
Q3 | – | Sell |
-550,000
| Closed | -$114M | – | 53 |
|
|
2018
Q2 | $114M | Buy |
+550,000
| New | +$114M | 3.62% | 8 |
|
|
2017
Q1 | – | Sell |
-94,980
| Closed | -$13.4M | – | 47 |
|
|
2016
Q4 | $13.4M | Buy |
+94,980
| New | +$13.4M | 0.76% | 29 |
|
|
2016
Q3 | – | Sell |
-233,245
| Closed | -$34.5M | – | 45 |
|
|
2016
Q2 | $34.5M | Sell |
233,245
-141,755
| -38% | -$20.9M | 1.88% | 17 |
|
|
2016
Q1 | $53.1M | Buy |
+375,000
| New | +$53.1M | 3.01% | 12 |
|
|
2015
Q3 | – | Sell |
-23,480
| Closed | -$3.05M | – | 54 |
|
|
2015
Q2 | $3.05M | Sell |
23,480
-44,620
| -66% | -$5.79M | 0.15% | 41 |
|
|
2015
Q1 | $9.15M | Sell |
68,100
-331,900
| -83% | -$44.6M | 0.44% | 37 |
|
|
2014
Q4 | $50.1M | Buy |
400,000
+344,700
| +623% | +$43.2M | 2.79% | 11 |
|
|
2014
Q3 | $6.73M | Buy |
+55,300
| New | +$6.73M | 0.35% | 33 |
|
|
2014
Q1 | – | Sell |
-26,500
| Closed | -$2.95M | – | 61 |
|
|
2013
Q4 | $2.95M | Sell |
26,500
-14,426
| -35% | -$1.61M | 0.18% | 43 |
|
|
2013
Q3 | $3.77M | Buy |
+40,926
| New | +$3.77M | 0.2% | 47 |
|